Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 105 citing Wong: Watchful waiting with periodic liver biopsy versus immediate empirical therapy for.... (0.07 sec) 

[PDF] Diagnosis, management, and treatment of hepatitis C


DB Strader, T Wright, DL Thomas, LB Seeff… - Hepatology, 2004 - texasliver.com
These recommendations provide a data-supported approach. They are based on the
following: (1) a formal review and analysis of the recently-published world
literature on the topic [Medline search]; (2) the American College of ...
Cited by 1057 - Related articles - View as HTML - All 11 versions

Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and …


F Sarasin, PE Majno, JM Llovet, J Bruix, G … - Hepatology, 2001 - interscience.wiley.com
Cadaveric liver transplantation (CLT) is an excellent treatment for early
hepatocellular carcinoma (HCC). Its use, however, is limited by the shortage of
grafts, with up to 30% of patients developing contraindications to the ...
Cited by 197 - Related articles - BL Direct - All 4 versions

[PDF] The role of liver biopsy in chronic hepatitis C


JL Dienstag - Hepatology, 2002 - hawaii.edu
The report of the 1997 National Institutes of Health Consensus Development
Conference on hepatitis C endorsed pretreatment liver biopsy. We revisit the
following questions: Does liver histology help determine the urgency of, ...
Cited by 179 - Related articles - View as HTML - BL Direct - All 7 versions

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to- …


K Patel, SC Gordon, I Jacobson, C Hézode, … - Journal of hepatology, 2004 - Elsevier
In chronic hepatitis C (CHC) infection, a liver biopsy provides important
information that guides treatment decisions, but is invasive, expensive and
associated with possible complications. Extracellular matrix remodeling ...
Cited by 180 - Related articles - All 9 versions

American Gastroenterological Association technical review on the management of hepatitis …


JL Dienstag, JG McHutchison - Gastroenterology, 2006 - Elsevier
In the United States, hepatitis C virus (HCV) infection accounts for
approximately 40% of all chronic liver disease, results in an estimated
8000–10,000 deaths annually, and is the most frequent indication for ...
Cited by 161 - Related articles - All 17 versions

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers …


C Colletta, C Smirne, C Fabris, P Toniutto, R … - Hepatology, 2005 - interscience.wiley.com
The course of hepatitis C virus (HCV) infection carriers with normal/near-normal
aminotransferases (NALT) is usually mild; however, in a few, fibrosis
progression occurs. We aimed to verify whether monitoring by liver biopsy ...
Cited by 129 - Related articles - BL Direct - All 3 versions

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient …

- googlepages.com [PDF] 
JA Salomon, MC Weinstein, JK Hammitt, SJ … - Jama, 2003 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Approximately 2.7 ...
Cited by 120 - Related articles - BL Direct - All 16 versions

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations …


V Soriano, M Puoti, M Sulkowski, A Cargnel, … - Aids, 2007 - journals.lww.com
The exact definition of persistently normal aminotransferases is not well
established in patients with chronic HCV infection. Fluctuations in
aspartate/alanine aminotransferases (AST/ALT) are frequent in HCV-related ...
Cited by 106 - Related articles - BL Direct - All 12 versions

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in …


G Sebastiani, A Vario, M Guido, F Noventa, M … - Journal of hepatology, 2006 - Elsevier
Three algorithms were developed: (1) significant fibrosis (F≥2 by METAVIR) was
identified with high diagnostic performance (>94% accuracy) using APRI as
screening test, followed by Fibrotest in APRI non-classified cases and ...
Cited by 102 - Related articles - All 9 versions

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy


G Sebastiani, A Alberti - World Journal of Gastroenterology, 2006 - wjgnet.com
Chronic liver diseases are very common worldwide, particularly those linked to
viral hepatitis and to alcoholic and non-alcoholic fatty liver. Their natural
history is variable and long-term evolution differs in individual patients. ...
Cited by 76 - Related articles - Cached - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google